山河药辅(300452.SZ)发布前三季度业绩，归母净利润1.33亿元，增长8.28%

Core Viewpoint - Shanhe Pharmaceutical Auxiliary (300452.SZ) reported a year-on-year increase in revenue and net profit for the first three quarters of 2025, indicating positive financial performance and growth potential [1] Financial Performance - The company's operating revenue for the first three quarters reached 697 million yuan, representing a year-on-year growth of 8.09% [1] - The net profit attributable to shareholders of the listed company was 133 million yuan, showing a year-on-year increase of 8.28% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 120 million yuan, reflecting a year-on-year growth of 14.02% [1] - Basic earnings per share stood at 0.57 yuan [1]